l-Arginine depletion blunts antitumor T-cell responses by inducing myeloid-derived suppressor cells.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Cancer Research

• Publication date

  2015-01-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-14-1491PMID 25406192PMCID PMC4297565
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The stress-response sensor chop regulates the function and accumulation of myeloid-derived suppressor cells in tumors.

  2014cited by this paper
• The targeting of immunosuppressive mechanisms in hematological malignancies

  2014cited by this paper
• The Central Role of Arginine Catabolism in T-Cell Dysfunction and Increased Susceptibility to Infection After Physical Injury

  2014cited by this paper
• Subpopulations of myeloid‐derived suppressor cells impair T cell responses through independent nitric oxide‐related pathways

  2014cited by this paper
• Functional polarization of tumour-associated macrophages by tumour-derived lactic acid

  2014cited by this paper
• Sweet nothings: sensing of sugar metabolites controls T cell function.

  2013cited by this paper
• Fueling Immunity: Insights into Metabolism and Lymphocyte Function

  2013cited by this paper
• Rapid effector function of memory CD8+ T cells requires an immediate-early glycolytic switch

  2013cited by this paper
• Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling.

  2013cited by this paper
• Metabolic response to pegylated arginine deiminase in mesothelioma with promoter methylation of argininosuccinate synthetase.

  2013cited by this paper
• Metabolic pathways in immune cell activation and quiescence.

  2013cited by this paper
• Targeting Arginine-Dependent Cancers with Arginine-Degrading Enzymes: Opportunities and Challenges

  2013cited by this paper
• Anti-leukemic mechanisms of pegylated arginase I in acute lymphoblastic T-cell leukemia

  2013cited by this paper
• Trp53 inactivation in the tumor microenvironment promotes tumor progression by expanding the immunosuppressive lymphoid-like stromal network.

  2013cited by this paper
• Posttranscriptional control of T cell effector function by aerobic glycolysis.

  2013cited by this paper
• Metabolism of L-Arginine by Myeloid-Derived Suppressor Cells in Cancer: Mechanisms of T cell suppression and Therapeutic Perspectives

  2012cited by this paper
• Recombinant human arginase toxicity in mice is reduced by citrulline supplementation.

  2012cited by this paper
• Coordinated regulation of myeloid cells by tumours

  2012cited by this paper
• A phase 1 dose-escalating study of pegylated recombinant human arginase 1 (Peg-rhArg1) in patients with advanced hepatocellular carcinoma

  2012cited by this paper
• Sustained generation of nitric oxide and control of mycobacterial infection requires argininosuccinate synthase 1.

  2012cited by this paper
• Cytotoxicity of human recombinant arginase I (Co)-PEG5000 in the presence of supplemental L-citrulline is dependent on decreased argininosuccinate synthetase expression in human cells

  2012cited by this paper
• Surgical Stress Resistance Induced by Single Amino Acid Deprivation Requires Gcn2 in Mice

  2012cited by this paper
• Recombinant human arginase inhibits the in vitro and in vivo proliferation of human melanoma by inducing cell cycle arrest and apoptosis

  2011cited by this paper
• The eIF2 kinase GCN2 is essential for the murine immune system to adapt to amino acid deprivation by asparaginase.

  2010cited by this paper
• Pegylated arginase I: a potential therapeutic approach in T-ALL.

  2010cited by this paper
• Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13.

  2010cited by this paper
• 5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity.

  2010cited by this paper
• l-Arginine Deprivation Regulates Cyclin D3 mRNA Stability in Human T Cells by Controlling HuR Expression

  2010cited by this paper
• Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients

  2009cited by this paper
• Enteral administration of alanyl-[2-(15)N]glutamine contributes more to the de novo synthesis of arginine than does intravenous infusion of the dipeptide in humans.

  2009cited by this paper
• Gemcitabine directly inhibits myeloid derived suppressor cells in BALB/c mice bearing 4T1 mammary carcinoma and augments expansion of T cells from tumor-bearing mice.

  2009cited by this paper
• Pegylated derivatives of recombinant human arginase (rhArg1) for sustained in vivo activity in cancer therapy: preparation, characterization and analysis of their pharmacodynamics in vivo and in vitro and action upon hepatocellular carcinoma cell (HCC)

  2009cited by this paper
• GCN2 Protein Kinase Is Required to Activate Amino Acid Deprivation Responses in Mice Treated with the Anti-cancer Agent l-Asparaginase*

  2009cited by this paper
• Role of arginine metabolism in immunity and immunopathology.

  2008cited by this paper
• Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives

  2008cited by this paper
• L-arginine availability regulates T-lymphocyte cell-cycle progression.

  2007cited by this paper
• Pegylated recombinant human arginase (rhArg-peg5,000mw) inhibits the in vitro and in vivo proliferation of human hepatocellular carcinoma through arginine depletion.

  2007cited by this paper
• Glutamine utilization by the small intestine.

  2006cited by this paper
• GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase.

  2005cited by this paper
• Uncharged tRNA and Sensing of Amino Acid Deficiency in Mammalian Piriform Cortex

  2005cited by this paper
• The GCN2 kinase biases feeding behavior to maintain amino acid homeostasis in omnivores.

  2005cited by this paper
• L-Arginine modulates CD3zeta expression and T cell function in activated human T lymphocytes.

  2004cited by this paper
• Arginase I Production in the Tumor Microenvironment by Mature Myeloid Cells Inhibits T-Cell Receptor Expression and Antigen-Specific T-Cell Responses

  2004cited by this paper
• L-arginine metabolism in myeloid cells controls T-lymphocyte functions.

  2003cited by this paper
• Randomised trial of glutamine-enriched enteral nutrition on infectious morbidity in patients with multiple trauma.

  1998cited by this paper
• The induction of citrulline synthesis from glutamine in enterocytes of weaned pigs is not due primarily to age or change in diet.

  1995cited by this paper
• Generation of a mouse model for citrullinemia by targeted disruption of the argininosuccinate synthetase gene

  1994cited by this paper
• Uptake and metabolism of plasma glutamine by the small intestine.

  1974cited by this paper

• Molecular mechanisms and therapies for tumor inhibition through the arginine metabolism pathway.

  2026cites this paper
• Systemic Multi-Omics Analysis Reveals Interferon Response Heterogeneity and Links Lipid Metabolism to Immune Alterations in Severe COVID-19

  2026cites this paper
• Hematopoietic Niche Hijacking in Bone Metastases: Roles of Megakaryocytes, Erythroid Lineage Cells, and Perivascular Stromal Subsets

  2026cites this paper
• The arginine metabolism and its deprivation in cancer therapy.

  2025cites this paper
• Epidermal and Dermal T Cells Exhibit Distinct Proteomic Signatures

  2025cites this paper
• Unveiling the crossroads of STING signaling pathway and metabolic reprogramming: the multifaceted role of the STING in the TME and new prospects in cancer therapies

  2025cites this paper
• Myeloid metabolism and its role in immunotherapy of cancer

  2025cites this paper
• Thymopentin Enhances Antitumor Immunity Through Thymic Rejuvenation and T Cell Functional Reprogramming

  2025cites this paper
• Metabolic Reprogramming of Tumor Microenviroment by Engineered Bacteria.

  2025cites this paper
• Global research trends and emerging themes in osteosarcoma metabolomics: a bibliometric and visualization analysis

  2025cites this paper
• Mechanisms of T-cell Depletion in Tumors and Advances in Clinical Research

  2025cites this paper
• Urea cycle dysregulation: a new frontier in cancer metabolism and immune evasion

  2025cites this paper
• Microbial metabolite-driven immune reprogramming in tumor immunotherapy: mechanisms and therapeutic perspectives

  2025cites this paper
• Tumor-induced metabolic immunosuppression: Mechanisms and therapeutic targets.

  2025cites this paper
• Harnessing myeloid cells in cancer

  2025cites this paper
• Immune checkpoint biology in hepatocellular carcinoma (Review)

  2025cites this paper
• Application of Metabolic Biomarkers in Breast Cancer: A Literature Review

  2025cites this paper
• Association of homoarginine with arginine and disease severity in COVID-19 patients

  2025cites this paper
• Amino acids metabolism: a potential target for cancer treatment

  2025cites this paper
• Multi-omics analysis reveals dynamic proteomic remodeling and metabonomic dysregulation underlying cytokine release syndrome in CAR-T-treated B-ALL.

  2025cites this paper
• Therapeutic potential of Traditional Chinese Medicine Yisui Shengxue pills to inhibit hypoxia-inducible factor-1alpha and general control nonderepressible 2 to regulate the post-chemotherapy immune response: integrating network pharmacology and experimental validation.

  2025cites this paper
• Metabolic checkpoints in immune cell reprogramming: rewiring immunometabolism for cancer therapy

  2025cites this paper
• Rewiring amino acids in cancer.

  2025cites this paper
• Arginine Competition in Tumor Microenvironment: A Potential Target for Cancer Therapy

  2025cites this paper
• Arginine metabolism in myeloid cells in health and disease

  2025cites this paper
• Arginine Metabolism in Cancer Biology and Immunotherapy

  2025influential citation
• Crosstalk between stromal, immune, and ovarian cancer cells in lipid-rich tumor microenvironment exhibits proliferative features

  2025cites this paper
• Cancer cell-derived arginine fuels polyamine biosynthesis in tumor-associated macrophages to promote immune evasion.

  2025cites this paper
• Neoadjuvant immunotherapy in squamous cell carcinoma of the head and neck: current evidence and future perspectives

  2025cites this paper
• Mechanistic roles and intervention strategies involving gut microbiota, amino acid metabolism, and the tumor immune microenvironment in MAFLD-HCC progression

  2025cites this paper
• Aptamers as immune checkpoint inhibitors in cancer immunotherapy: targeting CTLA-4/B7 and PD-1/PD-L1 pathways.

  2025cites this paper
• The Role of Tumor Microenvironment and Immune Cell Crosstalk in Triple-Negative Breast Cancer (TNBC): Emerging Therapeutic Opportunities.

  2025cites this paper
• Baihua Dangen Tang inhibits the peritoneal metastasis of colon cancer by modulating the bacterial metabolite gentisic acid to suppress MDSCs.

  2025cites this paper
• The Recruitment and Immune Suppression Mechanisms of Myeloid‐Derived Suppressor Cells and Their Impact on Bone Metastatic Cancer

  2025cites this paper
• SSRP1/SLC3A2 Axis in Arginine Transport: A New Target for Overcoming Immune Evasion and Tumor Progression in Peripheral T‐Cell Lymphoma

  2025cites this paper
• Arginine: at the crossroads of nitrogen metabolism

  2025cites this paper
• Enhancing the anti-tumor activity and reprogramming M2 macrophages by delivering siRNAs against SIRPα and STAT6 via M1 exosomes and combining with anti-PD-L1.

  2024cites this paper
• Gene expression levels associated with impaired immune response and increased proliferation could serve as biomarkers for women following cervical cancer screening programmes

  2024cites this paper
• Targeted modulation of myeloid-derived suppressor cells in the tumor microenvironment: Implications for cancer therapy.

  2024cites this paper
• Tumor Immune Microenvironment in Intrahepatic Cholangiocarcinoma: Regulatory Mechanisms, Functions, and Therapeutic Implications

  2024cites this paper
• The immunosuppressive landscape in tumor microenvironment

  2024cites this paper
• Effect of serum metabolites on the risk of iridocyclitis: a bidirectional Mendelian randomization study

  2024cites this paper
• Influence of Myeloid-derived Suppressor Cells in Tumor Immunotherapy

  2024cites this paper
• Spatiotemporal Controllable Sono‐Nanovaccines Driven by Free‐Field Based Whole‐Body Ultrasound for Personalized Cancer Therapy

  2024cites this paper
• Nutrients: Signal 4 in T cell immunity

  2024cites this paper
• 粒细胞样髓源性抑制细胞在非小细胞肺癌中的研究进展

  2024influential citation
• The immune microenvironment of cancer of the uterine cervix.

  2024cites this paper
• Targeting amino acid-metabolizing enzymes for cancer immunotherapy

  2024cites this paper
• Advancing immunotherapy for intrahepatic cholangiocarcinoma: exploring the tumor immune microenvironment and innovative treatments

  2024cites this paper
• GLUT1 overexpression in CAR-T cells induces metabolic reprogramming and enhances potency

  2024cites this paper
• Phenylalanine deprivation inhibits multiple myeloma progression by perturbing endoplasmic reticulum homeostasis

  2024cites this paper
• Cellular metabolism regulates the differentiation and function of T-cell subsets

  2024cites this paper
• Amino acid metabolism in immune cells: essential regulators of the effector functions, and promising opportunities to enhance cancer immunotherapy

  2023cites this paper
• A metabolic crosstalk between liposarcoma and muscle sustains tumor growth

  2023cites this paper
• Cancer immune exclusion: breaking the barricade for a successful immunotherapy

  2023cites this paper
• Durable control of metastases in an HLA-A2+ patient with refractory melanoma after low-dose radiotherapy in combination with MAGE-A4 T cell therapy: a case report

  2023cites this paper
• Same yet different — how lymph node heterogeneity affects immune responses

  2023cites this paper
• Effects of Human Chorionic Gonadotropin on Differentiation and Functional Activity of Myeloid-Derived Suppressor Cells

  2023cites this paper
• LncRNAs has been identified as regulators of Myeloid-derived suppressor cells in lung cancer

  2023cites this paper
• Amino acid metabolism reprogramming: shedding new light on T cell anti-tumor immunity

  2023cites this paper
• Metabolism-related long non-coding RNA in the stomach cancer associated with 11 AMMLs predictive nomograms for OS in STAD

  2023cites this paper
• Targeting cancer metabolic pathways for improving chemotherapy and immunotherapy.

  2023cites this paper
• Loss of Anti-Tumor Efficacy by Polyamine Blocking Therapy in GCN2 Null Mice

  2023cites this paper
• Partners in crime: The feedback loop between metabolic reprogramming and immune checkpoints in the tumor microenvironment

  2023cites this paper
• Interactions between Macrophages and Biofilm during Staphylococcus aureus-Associated Implant Infection: Difficulties and Solutions

  2023cites this paper
• High WFDC3 gene expression is associated with poor prognosis and reduced immune cells infiltration in pancreatic adenocarcinoma: A study using the TCGA database and bioinformatics analysis

  2023cites this paper
• Low albumin status accompanies multi-layered immunosuppressive phenotypes in metastatic breast cancer patients

  2023cites this paper
• Editorial: Proteomic and metabolic reprogramming in myeloma cells within the tumor microenvironment

  2023cites this paper
• Dietary Manipulation of Amino Acids for Cancer Therapy

  2023cites this paper
• New insights into T-cell exhaustion in liver cancer: from mechanism to therapy

  2023cites this paper
• Metabolites and Immune Response in Tumor Microenvironments

  2023cites this paper
• Tumor Immune Microenvironment in Gynecologic Cancers

  2023cites this paper
• Amino acid metabolism in health and disease

  2023cites this paper
• Advances in landscape and related therapeutic targets of the prostate tumor microenvironment

  2023cites this paper
• A novel metabolic subtype with S100A7 high expression represents poor prognosis and immuno-suppressive tumor microenvironment in bladder cancer

  2023cites this paper
• Secreted protease PRSS35 suppresses hepatocellular carcinoma by disabling CXCL2-mediated neutrophil extracellular traps

  2023cites this paper
• The Role of Metabolic Plasticity of Tumor-Associated Macrophages in Shaping the Tumor Microenvironment Immunity

  2022cites this paper
• Targeted Arginine Metabolism Therapy: A Dilemma in Glioma Treatment

  2022cites this paper
• Antibody-Mediated LILRB2-Receptor Antagonism Induces Human Myeloid-Derived Suppressor Cells to Kill Mycobacterium tuberculosis

  2022cites this paper
• Interleukin-33: Metabolic checkpoints, metabolic processes, and epigenetic regulation in immune cells

  2022cites this paper
• Chronic Stress-Related Gastroenteric Pathology in Cheetah: Relation between Intrinsic and Extrinsic Factors

  2022cites this paper
• New Immunometabolic Strategy Based on Cell Type-Specific Metabolic Reprogramming in the Tumor Immune Microenvironment

  2022cites this paper
• Beneficial effects of citrulline enteral administration on sepsis-induced T cell mitochondrial dysfunction

  2022cites this paper
• Polyamine Immunometabolism: Central Regulators of Inflammation, Cancer and Autoimmunity

  2022cites this paper
• Targeting Arginine in COVID-19-Induced Immunopathology and Vasculopathy

  2022cites this paper
• Influence of the Metabolism on Myeloid Cell Functions in Cancers: Clinical Perspectives

  2022cites this paper
• Molecular, cellular and systemic aspects of epithelial ovarian cancer and its tumor microenvironment.

  2022cites this paper
• Targeting myeloid-derived suppressor cells to enhance natural killer cell-based immunotherapy

  2022influential citation
• The Role of Myeloid-Derived Suppressor Cells in Establishing Immune Tolerance during Pregnancy

  2022cites this paper
• Encapsulation of Platinum Prodrugs into PC7A Polymeric Nanoparticles Combined with Immune Checkpoint Inhibitors for Therapeutically Enhanced Multimodal Chemotherapy and Immunotherapy by Activation of the STING Pathway

  2022cites this paper
• Metabolism heterogeneity in melanoma fuels deactivation of immunotherapy: Predict before protect

  2022cites this paper
• Metabolic Regulation of T cell Activity: Implications for Metabolic-Based T-cell Therapies for Cancer

  2022cites this paper
• The relationship between nutrition and the immune system

  2022cites this paper
• The Tumor Microenvironment Reprograms Immune Cells

  2022cites this paper
• Progress in research on the role of amino acid metabolic reprogramming in tumour therapy: A review.

  2022cites this paper
• Radiotherapy induced immunogenic cell death by remodeling tumor immune microenvironment

  2022cites this paper
• Role of myeloid-derived suppressor cells in the formation of pre-metastatic niche

  2022cites this paper
• Metabolic communication in the tumour–immune microenvironment

  2022cites this paper
• Virtual Screening for FDA-Approved Drugs That Selectively Inhibit Arginase Type 1 and 2

  2022cites this paper
• Arginine Supplementation Targeting Tumor-Killing Immune Cells Reconstructs the Tumor Microenvironment and Enhances the Antitumor Immune Response.

  2022cites this paper